Understanding the complex transcriptional and posttranslational regulation of eNOS highlights the therapeutic potential of eNOS gene therapy for vascular and ischemic diseases.
No takes yet. Share an insight, caveat, or question.
eNOS augmentation protects experimental vascular injury; leaves open safe, effective human translation.
Kenneth K. Wu (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: